Lockhart P - Search Results

1

alpha-Synuclein gene haplotypes are associated with Parkinson's disease.

Farrer M, Maraganore DM, Lockhart P, Singleton A, Lesnick TG, de Andrade M, West A, de Silva R, Hardy J, Hernandez D. Farrer M, et al. Among authors: lockhart p. Hum Mol Genet. 2001 Aug 15;10(17):1847-51. doi: 10.1093/hmg/10.17.1847. Hum Mol Genet. 2001. PMID: 11532993

2

Identification and characterization of the human parkin gene promoter.

West A, Farrer M, Petrucelli L, Cookson M, Lockhart P, Hardy J. West A, et al. Among authors: lockhart p. J Neurochem. 2001 Sep;78(5):1146-52. doi: 10.1046/j.1471-4159.2001.00512.x. J Neurochem. 2001. PMID: 11553688 Free article.

3

Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes.

West AB, Zimprich A, Lockhart PJ, Farrer M, Singleton A, Holtom B, Lincoln S, Hofer A, Hill L, Müller-Myhsok B, Wszolek ZK, Hardy J, Gasser T. West AB, et al. Among authors: lockhart pj. Eur J Hum Genet. 2001 Sep;9(9):659-66. doi: 10.1038/sj.ejhg.5200698. Eur J Hum Genet. 2001. PMID: 11571553

4

The human sideroflexin 5 (SFXN5) gene: sequence, expression analysis and exclusion as a candidate for PARK3.

Lockhart PJ, Holtom B, Lincoln S, Hussey J, Zimprich A, Gasser T, Wszolek ZK, Hardy J, Farrer MJ. Lockhart PJ, et al. Gene. 2002 Feb 20;285(1-2):229-37. doi: 10.1016/s0378-1119(02)00402-x. Gene. 2002. PMID: 12039050

5

Functional association of the parkin gene promoter with idiopathic Parkinson's disease.

West AB, Maraganore D, Crook J, Lesnick T, Lockhart PJ, Wilkes KM, Kapatos G, Hardy JA, Farrer MJ. West AB, et al. Hum Mol Genet. 2002 Oct 15;11(22):2787-92. doi: 10.1093/hmg/11.22.2787. Hum Mol Genet. 2002. PMID: 12374768

6

SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings.

Furtado S, Farrer M, Tsuboi Y, Klimek ML, de la Fuente-Fernández R, Hussey J, Lockhart P, Calne DB, Suchowersky O, Stoessl AJ, Wszolek ZK. Furtado S, et al. Among authors: lockhart p. Neurology. 2002 Nov 26;59(10):1625-7. doi: 10.1212/01.wnl.0000035625.19871.dc. Neurology. 2002. PMID: 12451209 Clinical Trial.

7

Accurate determination of ataxin-2 polyglutamine expansion in patients with intermediate-range repeats.

Hussey J, Lockhart PJ, Seltzer W, Wszolek ZK, Payami H, Hanson M, Gwinn-Hardy K, Farrer M. Hussey J, et al. Genet Test. 2002 Fall;6(3):217-20. doi: 10.1089/109065702761403397. Genet Test. 2002. PMID: 12490063

8

Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons.

Petrucelli L, O'Farrell C, Lockhart PJ, Baptista M, Kehoe K, Vink L, Choi P, Wolozin B, Farrer M, Hardy J, Cookson MR. Petrucelli L, et al. Among authors: lockhart pj. Neuron. 2002 Dec 19;36(6):1007-19. doi: 10.1016/s0896-6273(02)01125-x. Neuron. 2002. PMID: 12495618 Free article.

9

Identification of a novel gene linked to parkin via a bi-directional promoter.

West AB, Lockhart PJ, O'Farell C, Farrer MJ. West AB, et al. J Mol Biol. 2003 Feb 7;326(1):11-9. doi: 10.1016/s0022-2836(02)01376-1. J Mol Biol. 2003. PMID: 12547187

10

SCA2 may present as levodopa-responsive parkinsonism.

Payami H, Nutt J, Gancher S, Bird T, McNeal MG, Seltzer WK, Hussey J, Lockhart P, Gwinn-Hardy K, Singleton AA, Singleton AB, Hardy J, Farrer M. Payami H, et al. Among authors: lockhart p. Mov Disord. 2003 Apr;18(4):425-9. doi: 10.1002/mds.10375. Mov Disord. 2003. PMID: 12671950

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

504 results

Search Page